Cite
Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer.
MLA
Zhang, Zhizhu, et al. “Immunomodulatory Properties of PI3K/AKT/MTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer.” International Journal of Molecular Sciences, vol. 23, no. 13, July 2022, p. 7353–N.PAG. EBSCOhost, https://doi.org/10.3390/ijms23137353.
APA
Zhang, Z., Richmond, A., & Yan, C. (2022). Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 23(13), 7353–N.PAG. https://doi.org/10.3390/ijms23137353
Chicago
Zhang, Zhizhu, Ann Richmond, and Chi Yan. 2022. “Immunomodulatory Properties of PI3K/AKT/MTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer.” International Journal of Molecular Sciences 23 (13): 7353–N.PAG. doi:10.3390/ijms23137353.